Are there different patterns of detrusor overactivity which are clinically relevant? ICI-RS 2018.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 11 2018
revised: 09 12 2018
accepted: 29 01 2019
entrez: 11 12 2019
pubmed: 11 12 2019
medline: 20 5 2020
Statut: ppublish

Résumé

Different patterns of detrusor overactivity (DO) have been described and included in several standardization terminology documents. However, it is unclear if these different patterns have any clinical significance. This is a report of the proceedings of Proposal 3: "Are there different patterns of detrusor overactivity which are clinically relevant?" from the annual International Consultation on Incontinence-Research Society (ICIRS) meeting, which took place from 14 to 16 June 2018, in Bristol, UK. We have collected and discussed, as a committee, the evidence about different urodynamic (UD) patterns of detrusor overactivity and their potential clinical significance. We reviewed the important previous basic research and clinical studies and compiled summaries. The discussion focused on clinical relevance of different UD patterns of DO and what further research is required. There are several UD definitions of patterns of detrusor overactivity, however the clinical relevance of these definitions remains unclear. Future research should concentrate on defining the pattern of DO in relation to clinical diagnosis, gender, age, and treatment outcomes.

Identifiants

pubmed: 31821631
doi: 10.1002/nau.23964
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S40-S45

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Jerzy B Gajewski (JB)

Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada.

Andrew Gammie (A)

Bristol Urological Institute, Southmead Hospital, Bristol, UK.

John Speich (J)

Department of Mechanical and Nuclear Engineering, College of Engineering, Virginia Commonwealth University, Richmond, Virginia.

Ruth Kirschner-Hermanns (R)

Department of Neuro-Urology, University Hospital of the Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany.
Department of Urology and Paediatric Urology, Neuro-Urology, Neurological Rehabilitation Center "Godeshoehe e.V.", Bonn, Germany.

Stefan De Wachter (S)

Department of Urology, University of Antwerp, Antwerp, Belgium.

Brigitte Schurch (B)

Neurourology Unit Department of Neurosciences, University Hospital Lausanne, Lausanne, Switzerland.

Cees Korstanje (C)

Department of Drug Discovery Science & Management, Astellas Pharma Europe BV, Leiden, The Netherlands.

Francoise Valentini (F)

Université Pierre et Marie Curie, Hôpital Rothschild, Paris, France.

Mohammad Sajjad Rahnama'i (MS)

Uniklinik Aachen RWTH, Aachen, Germany.
Maastricht University, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH